Schwarzman Stephen A's Form 4 filing
Praxis Precision Medicines, Inc. (PRAX) · filed Aug 25, 2021
- Accession no.
- 0000899243-21-034149
- Filed
- Aug 25, 2021, 4:30 PM ET
- Trade date
- Aug 23, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $6.70M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwarzman Stephen ACIK 0001070844 | 10% Owner |
| Blackstone Inc.CIK 0001393818 | 10% Owner |
| Blackstone Group Management L.L.C.CIK 0001404071 | 10% Owner |
| Blackstone Holdings I L.P.CIK 0001464694 | 10% Owner |
| Blackstone Holdings I/II GP L.L.C.CIK 0001464695 | 10% Owner |
| Blackstone Holdings II L.P.CIK 0001484870 | 10% Owner |
| Blackstone Strategic Opportunity Associates L.L.C.CIK 0001728529 | 10% Owner |
| Blackstone Alternative Solutions L.L.C.CIK 0001728531 | 10% Owner |
| BSOF Parallel Master Fund L.P.CIK 0001736665 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.00 to $19.99, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.06, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.